These results indicate that HXL131 can inhibit the growth and metastasis of prostate cancer PC3 cells by targeting DUSP1 and TNFSF9, suggesting that DUSP1 and TNFSF9 are the direct targets of HXL131. This evidence concerns the gene TNFSF9 and prostate carcinoma.